Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues

Anticancer Research

Volumn 32, Issue 8, 2012, Pages 3219-3222

  Wang, Yufeng ^a   Kuramitsu, Yasuhiro ^a   Ueno, Tomio ^a   Suzuki, Nobuaki ^a   Yoshino, Shigefumi ^a   Iizuka, Norio ^a   Akada, Junko ^a   Kitagawa, Takao ^a   Oka, Masaaki ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Glyoxalase I; Pancreatic cancer

Indexed keywords

LACTOYLGLUTATHIONE LYASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE HOMOGENATE; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; UP-REGULATION;

EID: 84865696115     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Thornalley PJ: The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 269: 1-11, 1990.
2. Ranganathan S, Walsh ES, Godwin AK and Tew KD: Cloning and characterization of human colon glyoxalase-I. J Biol Chem 268: 5661-5667, 1993 .
3. Rulli A, Carli L, Romani R, Baroni T, Giovannini E, Rosi G and Talesa V: Expression of glyoxalase I and II in normal and breast cancer tissues. Breast Cancer Res Treat 66: 67-72, 2001.
4. Davidson SD, Cherry JP, Choudhury MS, Tazaki H, Mallouh C and Konno S: Glyoxalase I activity in human prostate cancer: a potential marker and importance in chemotherapy. J Urol 161: 690-691, 1999.
5. Sakamoto H, Mashima T, Sato S, Hashimoto Y, Yamori T and Tsuruo T: Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells. Clin Cancer Res 7: 2513-2518, 2001.
6. Sakamoto H, Mashima T, Kizaki A, Dan S, Hashimoto Y, Naito M and Tsuruo T: Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis. Blood 95: 3214-3218, 2000.
7. Bair WB 3rd, Cabello CM, Uchida K, Bause AS and Wondrak GT: GLO1 overexpression in human malignant melanoma. Melanoma Res 20: 85-96, 2010.
8. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
9. Kuramitsu Y, Harada T, Takashima M, Yokoyama Y, Hidaka I, Iizuka N, Toda T, Fujimoto M, Zhang X, Sakaida I, Okita K, Oka M and Nakamura K: Increased expression and phosphorylation of liver glutamine synthetase in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Electrophoresis 27: 1651-1658, 2006.
10. Mikuriya K, Kuramitsu Y, Ryozawa S, Fujimoto M, Mori S, Oka M, Hamano K, Okita K, Sakaida I and Nakamura K: Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol 30: 849-855, 2007.
11. Wang Y, Kuramitsu Y, Ueno T, Suzuki N, Yoshino S, Iizuka N, Zhang X, Oka M and Nakamura K: Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues. Oncol Rep 26: 1595-1599, 2011.
12. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Toda T, Sakaida I, Okita K, Oka M and Nakamura K: Proteomic profiling of heat-shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 12: 2487-2493, 2003.
13. Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Toda T, Terai S, Sakaida I, Oka M, Nakamura K and Okita K: Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 4: 2111-2116, 2004.
14. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Fujimoto M, Nishisaka T, Okita K, Oka M and Nakamura K: Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5: 1686-1692, 2005.
15. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, Mikuria K, Fujimoto M, Maehara S, Maehara Y, Okita K, Nakamura K and Sakaida I: Proteomics finding heat-shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 31: 1345-1350, 2007.
16. Kuramitsu Y, Takashima M, Yokoyama Y, Iizuka N, Tamesa T, Akada JK, Wang Y, Toda T, Sakaida I, Okita K, Oka M and Nakamura K: Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. Anticancer Res 31: 3331-3336, 2011.
17. Kawase M, Tada M, Akagi S and Ohmori S: Changes in concentrations of methylglyoxal, D-lactate and glyoxalase activities in liver and plasma of rats fed a 3′-methyl-4-dimethylaminoazobenzene-rich diet. Res Exp Med (Berl) 196: 251-259, 1996.
18. van Heijst JW, Niessen HW, Hoekman K and Schalkwijk CG: Advanced glycation end products in human cancer tissues: detection of nepsilon-(carboxymethyl)lysine and argpyrimidine. Ann NY Acad Sci 1043: 725-733, 2005.
19. van Heijst JW, Niessen HW, Musters RJ, van Hinsbergh VW, Hoekman K and Schalkwijk CG: Argpyrimidine-modified heat-shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis. Cancer Lett 241: 309-319, 2006.
20. Ranganathan S, Walsh ES and Tew KD: Glyoxalase I in detoxification: studies using a glyoxalase I transfectant cell line. Biochem J 309: 127-131, 1995.
21. Sharkey EM, O'Neill HB, Kavarana MJ, Wang H, Creighton DJ, Sentz DL and Eiseman JL: Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I. Cancer Chemother Pharmacol 46: 156-166, 2000.
22. Santel T, Pflug G, Hemdan NY, Schäfer A, Hollenbach M, Buchold M, Hintersdorf A, Lindner I, Otto A, Bigl M, Oerlecke I, Hutschenreuther A, Sack U, Huse K, Groth M, Birkemeyer C, Schellenberger W, Gebhardt R, Platzer M, Weiss T, Vijayalakshmi MA, Krüger M and Birkenmeier G: Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and antitumor activity. PLoS One 3: e3508, 2008.
23. Thornalley PJ and Rabbani N: Glyoxalase in tumourigenesis and multidrug resistance. Semin Cell Dev Biol 22: 318-325, 2011.
24. Santarius T, Bignell GR, Greenman CD, Widaa S, Chen L, Mahoney CL, Butler A, Edkins S, Waris S, Thornalley PJ, Futreal PA and Stratton MR: GLO1-A novel amplified gene in human cancer. Genes Chromosomes Cancer 49: 711-725, 2010.
25. Kang Y, Edwards LG and Thornalley PJ: Effect of methylglyoxal on human leukaemia 60 cell growth: modification of DNA G 1 growth arrest and induction of apoptosis. Leuk Res 20: 397-405, 1996.
26. Speer O, Morkunaite-Haimi S, Liobikas J, Franck M, Hensbo L, Linder MD, Kinnunen PK, Wallimann T and Eriksson O: Rapid suppression of mitochondrial permeability transition by methylglyoxal. Role of reversible arginine modification. J Biol Chem 278: 34757-34763, 2003.
27. Chan WH, Wu HJ and Shiao NH: Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. J Cell Biochem 100: 1056-1069, 2007.
28. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y and Katagiri T: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23: 2385-2400, 2004.
29. Long J, Zhang Y, Yu X, Yang J, LeBrun DG, Chen C, Yao Q and Li M: Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets 15: 817-828, 2011.